Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEMPO: Etanercept and Methotrexate in RA
NCT00393471Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 2000
- Modality
- Fc-Fusion Proteins
- Countries
- 19
01
Overview
A Phase 3 trial of etanercept in rheumatoid arthritis (RA), sponsored by Pfizer. Started Oct 2000; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00393471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00393471.